Strategic Issues in Vaccine Research (SIVR) Program Update, 2007 Ben Schwartz, NVPO NVAC June 2007.

Slides:

Advertisements

Similar presentations

1 Strategic Plan Review. 2 Process Planning and Evaluation Committee will be discussing 2 directions per meeting. October meeting- Finance and Governance.

Advertisements

The NVPO Unmet Needs Program: FY 2006 Update Ben Schwartz National Vaccine Program Office National Vaccine Advisory Committee Meeting, June 2006.

ACIP Meeting Update November 4 th

OJJDP Performance Measurement Training 1 Incorporating Performance Measurement in the Formula Grant RFP and Application Format Presenter: Pat Cervera,

1 THE UNIT SERVICE PLAN. 2 3 The Basics A game with a purpose… If we build it… …they will come… …and… …they will stay. Helping units succeed. An impact.

TM Aggregate Reporting of Pandemic Influenza Vaccine Doses Administered Using CDC’s Countermeasure & Response Administration (CRA) System and State Immunization.

Presented by Margaret Shandorf

MARPHLI Cutting-Edge Issues in Management and Leadership Bradley A. Perkins, MD, MBA Director Office of Strategy and Innovation,

HealthSanté CanadaCanada Influenza Prevention and Control in Canada Arlene King, MD, MHSc, FRCPC Director, Immunization and Respiratory Infections Division,

Emerging Latino Communities Initiative Webinar Series 2011 June 22, 2011 Presenter: Janet Hernandez, Capacity-Building Coordinator.

A program of the International Association of Immunization Managers Peer-to-Peer Exchange HPV Vaccination in Ireland Dr. Brenda Corcoran for Molly Howell,

TM Prepared for your next patient. Review of Selected Changes to the 2012 Immunization Schedules H. Cody Meissner, MD Floating Hospital for Children Tufts.

H1N1 and Seasonal Influenza Surveillance among American Indian Mothers using Pregnancy Risk Assessment and Monitoring System (PRAMS) data 1 Myra Tucker,

1 Oregon’s Key Performance Measurement (KPM) System KPM Review Processes Prepared for the Interim Joint Committee on Ways and Means October 16, 2008.

A double-blinded, controlled study of the efficacy, immunogenicity, safety and tolerability, and effectiveness of a pneumococcal conjugate vaccine containing.

Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Staffing and Training.

Presentation to Contra Costa County Climate Leaders October 3, 2013.

City Council October 21, 2013 Strategic Planning Retreat Next Steps.

Adult Immunization at CDC Gina T. Mootrey, DO, MPH NVAC, October 22, 2007.

Communications Committee Update Ryan Roberts, NFHP Staff March 9, 2014.

1 Sex/Gender and Minority Inclusion in NIH Clinical Research What Investigators Need to Know! Presenter: Miriam F. Kelty, PhD, National Institute on Aging,

5th Annual Advocacy Project: ImmuneWise Section on Medical Students, Residents, and Fellowship Trainees

Multi-Year Plans Strengthening immunization systems and introduction of hepatitis B vaccine in Central Europe and the Newly Independent States St. Petersburg,

Implementing New Vaccines and Vaccine Recommendations National Vaccine Advisory Committee Washington, DC September 26, 2006 Lance E. Rodewald, MD Director,

Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.

U.S. Pandemic Influenza Preparedness and Response: Update & Progress Report “The pandemic influenza clock is ticking. We just don’t know what time it is.”

Update of The National Vaccine Plan Bruce G. Gellin, M.D., M.P.H., and Raymond A. Strikas, MD National Vaccine Program Office Department of Health and.

America Responds: An HHS 2009-H1N1 Retrospective to Advance All Hazards Preparedness Discussion with the National Vaccine Advisory Committee June 3, 2010.

National Vaccine Advisory Committee Report from the Chair Gus Birkhead, MD, MPH NVAC Chair June 2, 2010.

1 Vaccines and Related Biological Products Advisory Committee Meeting November 18, 2009 Questions for the Committee Prevnar 13 Pneumococcal 13-valent Conjugate.

1 Strategic Plan Review. 2 Process Planning and Evaluation Committee will be discussing 2 directions per meeting. October meeting- Finance and Governance.

2005 AHIP Immunization Assessment Summary National Vaccine Advisory Committee November 29-30, 2005 Steve Black, MD, AHIP Liaison to NVAC Bob Rehm, Director.

National Vaccine Advisory Committee Report from the Chair Gus Birkhead, MD, MPH NVAC Chair February 3, 2010.

Strategic Plan Review Drawing a Picture & Sharing a Story.

(Slide 1 of 22) Response to the National Vaccine Advisory Committee Recommendations on the Immunization Safety Office Scientific Agenda Frank DeStefano,

Strategies to Consider to Improve ACCV Effectiveness Presentation to ACCV Vito Caserta M.D., M.P.H. Vincent Matanoski, J.D. December 5,

Influenza Jeffrey S. Duchin, M.D. Chief, Communicable Disease Control, Epidemiology and Immunization Section, Public Health - Seattle & King County Division.

NVAC Influenza Vaccine Recommendations and Strategies Subgroup Members: Jerome Klein (Chair), Jeff Davis, Jon Abramson, Carolyn Bridges, Nancy Cox, Ben.

COMMUNITY HEALTH IMPROVEMENT PLAN (CHIP) ANNUAL UPDATE REPORT Health Care Access Committee September 28, 2015.

Strengthening the Delivery of New Vaccines for Adolescents A National Stakeholders' Meeting Washington DC June 2-3, 2005.

1 Nanoscale Materials Stewardship Program Environmental Summit May 20, 2008 Jim Alwood Chemical Control Division Office of Pollution Prevention and Toxics.

Assuring coverage with newly introduced vaccines: Perception, Program, & Financing Alan R. Hinman, MD, MPH Subcommittee on Immunization Coverage June 7,

OFFICE OF VACCINES RESEARCH AND REVIEW Center for Biologics Evaluation and Research Michael J. Brennan, Ph.D. Associate Director for Research OVRR Site.

NVAC Influenza Working Group Vaccine Research, Development and Production.

Information Overview SF: Planning & Programming Workshops for EC Delegation Patrick Colgan & Ján Krištín PROGRAMMING PROCEDURES in Support of Regional.

Joint Meeting of the Coverage and Future Vaccines Subcommittees October 5, 2004.

Discussion of Priority Activities for Next Eighteen Months Action Plans.

Non-institutionalized adults vaccinated annually against influenza and ever vaccinated against pneumococcal disease. Healthy Kansans 2010 Steering Committee.

Pandemic Influenza: Planning and Preparedness Ben Schwartz, M.D. National Vaccine Program Office, U.S. Department of Health and Human Services NVAC Meeting,

The University of Toledo Finance and Audit Committee Meeting “Internal Audit and Compliance Update” August 12, 2013.

Adult Immunization: Goals, Challenges, and a role for the National Vaccine Advisory Committee October 22, 2007 Raymond A. Strikas, MD National Vaccine.

Runaway and Homeless Youth Act Public Policy Update Presentation to National Safe Place March 10, 2010 by Bob Reeg Public Policy Director National Network.

The National Vaccine Plan Update: Recent Activities and Next Steps Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human.

HHS Secretary’s Advisory Committee on Blood Safety and Availability Summary of November 2010 ACBSA for FDA’s BPAC December 2010 CDR Richard Henry, USPHS.

Web Evaluation Examples Library 10 –Information Competency.

Hot Topic Meeting by: Royal College of Physicians of Edinburgh & The Scottish Executive Health Department Pandemic Flu Planning Scotland’s Health Response.

The Department of Early Education and Care 2013 Annual Legislative Report February 11, 2014.

The NVPO Unmet Needs Program: Looking Back and Moving Forward Ben Schwartz National Vaccine Program Office National Vaccine Advisory Committee Meeting,

Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.

Delivering Results and Satisfaction: Strategic Planning for Information Professional Leaders and Managers SLA 2016 Annual Conference Donald Malcolm Smith,

Draft Guidance on Prioritization of Pandemic Influenza Vaccine Who should get vaccinations first? Benjamin Schwartz, M.D. National Vaccine Program Office,

Risk Assessment ABOR Audit Committee April 5, 2017

Epidemiology Section APHA Tuesday, Nov. 6, 2007

University Open Forum April 30, 2018

Conversation with Kent on Budget Matters

Customer Service Working Group

Customer Service Call Center Update

Customer Service Working Group

Baltic Sea Region Strategy

March 8, 2006 New ACIP Hepatitis B Recommendations

Presentation transcript:

Strategic Issues in Vaccine Research (SIVR) Program Update, 2007 Ben Schwartz, NVPO NVAC June 2007

Program Name Change From: Unmet Needs To: Strategic Issues in Vaccine Research (SIVR)

SIVR FY 2007 Process 5 priority topics established with NVAC input –Vaccine safety, adolescent vaccination, vaccine economics and financing, public engagement, and improved diagnostic tests for VPDs Agency scientists submit proposals 2-step review process –Initial review by NVPO, agency, and NVAC reviewers –In-person review with NVAC reviewers (7) and NVPO staff (3) scoring proposals

SIVR Funding in FY 2007 Total funding ~$4 million –19 continuation projects; 12 new projects –Average award $129,000 (range $71,000 - $240,000) Priority topics for continuation projects –New and future vaccines – 9 Vaccine development (5); new vaccine evaluation (4) –Annual and pandemic influenza – 5 –Vaccine safety – 3 –Adolescent vaccination – 2 Of 12 new projects funded, 9 included interagency collaborations

SIVR Funding in FY 2007: New Projects Adolescent vaccination – 4 –Evaluating the scientific basis for adolescent MMR vaccination –Case control study of Tdap VE in adolescents –Use of State laws to permit adolescent consent for vaccinations –NP carriage of meningococci following meningococcal conjugate vaccination Vaccine safety – 3 –Meeting on the genetic basis for vaccine safety –Background intussusception rates in infants managed with short stay or emergency room care –Rapid assessment of influenza vaccine safety using Medicare data

SIVR Funding in FY 2007: New Projects Improved methods for VPD detection – 3 –Development of a multiplexed PCR for pneumococcal diagnosis and serotyping –Development of a rapid HPV antibody test –Improved methods to detect and genotype wild-type and vaccine rotavirus strains Public engagement – 1 –Development and implementation of an adolescent immunization and public engagement campaign targeting Native American and Asian youth Vaccine economics and financing – 1 –Modeling the impact and cost effectiveness of HPV vaccination strategies

FY 2007 New Proposal Success Rates by Priority Category Priority areaApproved/submittedFunding rate Adolescent vaccination 4/1429% Diagnostic tests for VPDs 3/1127% Public engagement1/425% Vaccine economics and financing 1/617% Vaccine safety3/2413%

SIVR Program Monitoring, Evaluation, and Information Sharing 6-monthly progress reports –Standard 2-page form being developed End of project report 1 and 2-year post-completion updates –Publications and presentations –Continuation and follow-up activities SIVR seminar series –Investigators report study progress and results

SIVR for FY 2008: Issues for NVAC Discussion Priority topics –Same priority topics or new priorities? Proposal review process –Comments or suggestions for improvement? Timeline –Retain same schedule or implement earlier process? Solicitation late-August Proposals due mid-October Review committee meeting early-December